Computed tomography-based radiomics predicts the fibroblast-related gene EZH2 expression level and survival of hepatocellular carcinoma

Table 3 Correlation between risk scores in clinical features and hepatocellular carcinoma prognosis

Characteristic	Total, n	Multivariate analysis
		Hazard ratio (95%CI)	P value
Risk score	339	5.339 (3.139-9.078)	< 0.001
Age	339	1.018 (1.002-1.034)	0.028
Sex	339	1.010 (1.006-1.014)	0.172
Grade	339	1.113 (0.744-1.664)	0.603
Stage	339	0.888 (0.579-1.363)	0.588

CI: Confidence interval.